Utah Medical Products
UTMD
UTMD
90 hedge funds and large institutions have $247M invested in Utah Medical Products in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 29 increasing their positions, 38 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
90
Holders Change
-6
Holders Change %
-6.25%
% of All Funds
1.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
29
Reduced
38
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$1.17M |
| 2 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$693K |
| 3 |
Nuveen Asset Management
Chicago,
Illinois
|
+$635K |
| 4 |
ProShare Advisors
Bethesda,
Maryland
|
+$493K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$427K |
Top Sellers
| 1 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$2.74M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$2.48M |
| 3 |
PC
Port Capital
Chicago,
Illinois
|
-$1.95M |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$1.91M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.89M |
